Ute Hofmann

9.4k total citations
183 papers, 6.3k citations indexed

About

Ute Hofmann is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ute Hofmann has authored 183 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 50 papers in Pharmacology and 49 papers in Oncology. Recurrent topics in Ute Hofmann's work include Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (39 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Ute Hofmann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (47 papers), Drug Transport and Resistance Mechanisms (39 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Ute Hofmann collaborates with scholars based in Germany, Egypt and United States. Ute Hofmann's co-authors include Matthias Schwab, Michel Eichelbaum, Ulrich M. Zanger, Gerd Mikus, Elke Schaeffeler, Kathrin Klein, Michel Eichelbaum, Martin F. Fromm, Joachim E. Fischer and Klaus Eckhardt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ute Hofmann

179 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ute Hofmann Germany	45	1.9k	1.7k	1.6k	983	743	183	6.3k
Lauren M. Aleksunes United States	48	2.2k 1.2×	2.8k 1.7×	1.4k 0.9×	1.2k 1.2×	668 0.9×	168	7.0k
Deanna L. Kroetz United States	46	3.1k 1.6×	3.1k 1.8×	1.9k 1.2×	1.4k 1.4×	655 0.9×	133	8.6k
In‐Jin Jang South Korea	40	1.6k 0.8×	1.5k 0.9×	1.2k 0.7×	777 0.8×	751 1.0×	306	5.9k
Toshiyuki Sakaeda Japan	45	2.8k 1.5×	2.1k 1.2×	974 0.6×	1.4k 1.4×	1.0k 1.3×	220	7.1k
Kathrin Klein Germany	44	2.9k 1.6×	1.8k 1.1×	3.6k 2.2×	1.3k 1.3×	586 0.8×	112	7.7k
Stephan Krähenbühl Switzerland	50	1.4k 0.7×	3.0k 1.8×	1.5k 0.9×	733 0.7×	1.0k 1.4×	227	8.6k
Caroline F. Thorn United States	35	1.3k 0.7×	2.2k 1.3×	2.0k 1.3×	969 1.0×	391 0.5×	58	6.9k
Jukka Hakkola Finland	44	1.1k 0.6×	1.6k 1.0×	2.1k 1.3×	699 0.7×	297 0.4×	93	5.2k
Ron H. N. van Schaik Netherlands	53	2.7k 1.5×	2.1k 1.2×	2.8k 1.7×	2.2k 2.2×	1.1k 1.5×	242	9.3k
Ichiro Ieiri Japan	45	3.3k 1.7×	1.2k 0.7×	2.1k 1.3×	1.9k 1.9×	794 1.1×	176	6.4k

Countries citing papers authored by Ute Hofmann

Since Specialization

Citations

This map shows the geographic impact of Ute Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hofmann more than expected).

Fields of papers citing papers by Ute Hofmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hofmann. The network helps show where Ute Hofmann may publish in the future.

Co-authorship network of co-authors of Ute Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Hofmann. A scholar is included among the top collaborators of Ute Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Hofmann. Ute Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zizmare, Laimdota, Ute Hofmann, Mohamed Ali Jarboui, et al.. (2025). Cryogenic mouse tissue homogenization as an alternative to fresh-frozen biopsy use for genomics, transcriptomics, proteomics and metabolomics. Scientific Reports. 15(1). 20254–20254.

Kinzig, Martina, et al.. (2024). A high performance liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of 10 drug compounds commonly used for antimicrobial therapy in plasma and serum of critically ill patients: Method optimization, validation, cross-validation and clinical application. Clinica Chimica Acta. 559. 119690–119690. 3 indexed citations

Burhenne, Jürgen, Johanna Weiß, Mathias Haag, et al.. (2023). Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology. 14. 1128547–1128547. 4 indexed citations

Ghallab, Ahmed, Reham Hassan, Ute Hofmann, et al.. (2023). In vitro to in vivo acetaminophen hepatotoxicity extrapolation using classical schemes, pharmacodynamic models and a multiscale spatial-temporal liver twin. Frontiers in Bioengineering and Biotechnology. 11. 1049564–1049564. 7 indexed citations

Shafagh, Reza Zandi, et al.. (2023). Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments. Advanced Healthcare Materials. 13(11). e2303561–e2303561. 16 indexed citations

BOLOGNESE, A., Stefano Fornasaro, Ute Hofmann, et al.. (2023). SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells. Chemico-Biological Interactions. 387. 110792–110792. 2 indexed citations

Hofmann, Ute, et al.. (2023). Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS. Talanta. 260. 124578–124578. 1 indexed citations

Reustle, Anna, Ute Hofmann, Viktoria Stühler, et al.. (2022). Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Clinical and Translational Medicine. 12(6). e883–e883. 26 indexed citations

Montes‐Mojarro, Ivonne A., Julia Steinhilber, Christoph M. Griessinger, et al.. (2022). CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL. Leukemia. 36(8). 2050–2063. 9 indexed citations

10.

Weller, Sandra, Kathrin Böpple, Ute Hofmann, et al.. (2022). The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA. Cell Death Discovery. 8(1). 215–215. 21 indexed citations

11.

Seitz, Andreas, Astrid Hubert, Sascha Beck, et al.. (2021). Repurposing Riociguat for Treatment of Refractory Angina Resulting From Coronary Spasm. SHILAP Revista de lepidopterología. 3(3). 392–396. 9 indexed citations

12.

Gierke, Berthold, Michael Pawlak, Ute Hofmann, et al.. (2020). Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression. Breast Cancer Research. 22(1). 13–13. 43 indexed citations

13.

Hofmann, Ute, et al.. (2020). Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids. Thyroid. 31(6). 973–984. 14 indexed citations

14.

Sprenger, Heike, Ute Hofmann, Felix F. Schmidt, et al.. (2020). Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells. International Journal of Molecular Sciences. 22(1). 372–372. 49 indexed citations

15.

Matthaei, Johannes, Mladen V. Tzvetkov, Daniel Sehrt, et al.. (2016). Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters. Genome Medicine. 8(1). 119–119. 10 indexed citations

16.

Luckert, Claudia, Christina Schulz, Maria Thomas, et al.. (2016). Comparative analysis of 3D culture methods on human HepG2 cells. Archives of Toxicology. 91(1). 393–406. 86 indexed citations

17.

Nies, Anne T., Elke Schaeffeler, Heiko van der Kuip, et al.. (2013). Cellular Uptake of Imatinib into Leukemic Cells Is Independent of Human Organic Cation Transporter 1 (OCT1). Clinical Cancer Research. 20(4). 985–994. 52 indexed citations

18.

Mürdter, Thomas E., Janet K. Coller, Alexander Claviez, et al.. (2001). Sensitive and Rapid Quantification of Busulfan in Small Plasma Volumes by Liquid Chromatography–Electrospray Mass Spectrometry. Clinical Chemistry. 47(8). 1437–1442. 38 indexed citations

19.

Dilger, Karin, Klaus Eckhardt, Ute Hofmann, et al.. (1999). Chronopharmacology of intravenous and oral modified release verapamil. British Journal of Clinical Pharmacology. 47(4). 413–419. 25 indexed citations

20.

Hofmann, Ute, et al.. (1981). Sequential formation of des a fibrin and des ab fibrin and binding of fibrinogen to des ab fibrin. Thrombosis and Haemostasis. 46(1). 181. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact